Results
Jagsonpal Pharmaceuticals FY26 Results: Dividend, Buyback, Acquisition
Jagsonpal Pharmaceuticals reported FY26 revenue growth of 6.9% to ₹2,872 million with 19% PAT growth to ₹446 million, maintaining strong liquidity position.
The company declared ₹4 per share dividend
